Tamoxifen Monotherapy. NCCP National SACT Regimen. HSE.

Regulatory approval published by the Health Service Executive. Deprecated

Citation

Tamoxifen Monotherapy, 2026, version number 6, NCCP National SACT Regimen, NCCP, viewed 02/08/2026, https://healthservice.hse.ie/documents/6357/253_v5_Tamoxifen_Monotherapy.pdf

Regulatory approvals

Approved indications from this document for cancer drugs containing at least one biomarker.

Indication	Statements

Therapeutic response

Precision oncology relationships for therapeutic response derived from this document.

Organizations	Biomarkers	Cancer types	Therapies